NCT06274541 2024-02-23
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
Cancer Trials Ireland
Unknown
Clinical Trials
11 trialsNCT06223763 2024-01-25
SUROVA
Clinica Universidad de Navarra, Universidad de Navarra
Unknown
NCT05537844 2022-09-23
BriTROC-2
Cancer Research UK, Glasgow
Unknown
NCT01366183 2021-09-30
Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
GOG Foundation
Unknown
NCT03000192 2021-03-17
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
University Hospital Southampton NHS Foundation Trust
Unknown
NCT04402333 2020-09-02
MIRRORS
Royal Surrey County Hospital NHS Foundation Trust
Unknown
NCT00499512 2020-01-10
Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer
M.D. Anderson Cancer Center
Unknown
NCT01372787 2019-03-12
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
GOG Foundation
Unknown
NCT02478476 2015-06-23
DNA Single Nucleotide Polymorphisms as Predictors of Toxicity
OvaGene Oncology, Inc.
Unknown
NCT00897039 2013-09-20
Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Unknown
NCT01074398 2010-02-24
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
National Cancer Institute (NCI)
Unknown